Yiran Gan 4/4/25 Yiran Gan 4/4/25 Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Characterization of magnetic relaxation when biofunctionalized magnetic nano-particles are associated with biomarkers in the liquid state in biomedical applications Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease Read More Newer Posts Older Posts
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Characterization of magnetic relaxation when biofunctionalized magnetic nano-particles are associated with biomarkers in the liquid state in biomedical applications Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease Read More
